HomeMarket NewsSmall CapsWhy SenesTech Shares Are Trading Lower By Around 50%? Here Are Other...

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Actionable Trade Ideas

always free

Table of Contents hide

image20

Shares of SenesTech, Inc. SNES shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

SenesTech company priced a public offering of around 3.8 million shares of common stock at $1.30 per share, alongside warrants for additional shares.

SenesTech shares declined 50.3% to $0.9189 on Tuesday.

Here are some other stocks moving in today’s mid-day session.

Gainers

  • IceCure Medical Ltd ICCM jumped 90% to $1.44 after the company announced the latest release of a study in a series of independent studies of ProSense published in peer-reviewed journals demonstrating safety and efficacy.
  • RedHill Biopharma Ltd. RDHL gained 90% to $1.90. Redhill Biopharma announced the FDA has granted five years’ market exclusivity for Talicia.
  • HNR Acquisition Corp HNRA gained 67% to $2.89 after the company gave a business update.
  • Fusion Fuel Green PLC HTOO rose 39.6% to $1.25.
  • Carbon Revolution Public Limited Company CREV gained 30% to $33.55 after Craig-Hallum initiated coverage on the stock with a Buy rating and a $84 price target.
  • ESGL Holdings Limited ESGL gained 29.6% to $1.1590 as the company disclosed a multi-year contract renewal with Singapore Refining Company Private Limited.
  • Bitfarms Ltd. BITF gained 24.5% to $1.3200. The company announced upgrades for its mining fleet.
  • Arcimoto, Inc. FUV rose 23.7% to $1.0892.
  • Gyre Therapeutics, Inc. GYRE gained 23.5% to $25.85.
  • Farfetch Limited FTCH gained 21.9% to $2.0850 following a report suggesting the company’s founder may be in talks to take the company private.
  • Avidity Biosciences, Inc. RNA surged 21.3% to $7.47 after the company reported expansion of cardiovascular collaboration with Bristol Myers Squibb.
  • Cardio Diagnostics Holdings, Inc. CDIO climbed 20.4% to $2.7209.
  • SpringWorks Therapeutics, Inc. SWTX gained 19.1% to $24.73. The FDA approved SpringWorks Therapeutics’ Ogsiveo (nirogacestat), an oral gamma-secretase inhibitor, for adult patients with progressing desmoid tumors who require systemic treatment.
  • PDD Holdings Inc. PDD shares gained 18% to $138.90 following third-quarter results.
  • CleanSpark, Inc. CLSK rose 13.3% to $6.32.
  • Cheche Group Inc. CCG surged 12.3% to $6.17.
  • Clearway Energy, Inc. CWEN gained 11.4% to $25.48. Clearway Energy will replace Veritiv in the S&P SmallCap 600.
  • LendingClub Corporation LC climbed 10.6% to $6.17. Piper Sandler initiated coverage on LendingClub with an Overweight rating and announced a price target of $8.
  • Lilium N.V. LILM gained 10.4% to $1.0050. Lilium announced it received EASA Design Organization Approval.
  • Marathon Digital Holdings, Inc. MARA climbed 8.2% to $12.21.
  • The Carlyle Group Inc. CG rose 5.1% to $34.48. Carlyle Group will replace ICU Medical in the S&P MidCap 400, effective prior to the open of trading on Nov. 30.

Losers

  • Tharimmune, Inc. THAR shares fell 72.8% to $0.9499. Tharimmune priced its $10 million public offering 10 million common shares at $1 per share.
  • Cabaletta Bio, Inc. CABA fell 31.9% to $12.73 after the FDA said it was investigating a risk of T-cell malignancies in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.
  • Acelyrin, Inc. SLRN declined 31.6% to $5.94 after the company announced an error in its Phase 2b/3 trial for izokibep. The company said the error has been addressed and the dosing sequence has been fixed.
  • Biodexa Pharmaceuticals Plc BDRX fell 31.2% to $3.5195 after the company announced an offering of 1,397,849 Class A units at an assumed public offering price of $2.79 per Class A unit.
  • iBio, Inc. IBIO fell 28% to $0.2078 after the company announced a 20-to-1 reverse stock split.
  • CohBar, Inc. CWBR fell 23.2% to $0.6901.
  • Gracell Biotechnologies Inc. GRCL declined 13.6% to $4.6650. Gracell Biotechnologies recently announced it received FDA clearance of the IND application for the Phase 1/2 clinical trial of FasTCAR-T GC012F for the treatment of refractory systemic lupus erythematosus.
  • Erasca, Inc. ERAS declined 11.6% to $1.98 after announcing program updates.
  • argenx SE ARGX fell 10.5% to $443.67 after the company reported the ADVANCE-SC study evaluating VYVGART Hytrulo in adults with primary immune thrombocytopenia did not meet primary or secondary endpoints.
  • Allego N.V. ALLG declined 9.6% to $1.2650.
  • Luminar Technologies, Inc. LAZR fell 9.6% to $2.3750.
  • Mission Produce, Inc. AVO fell 7.1% to $8.24. Roth MKM maintained Mission Produce with a Buy and lowered the price target from $18 to $12.5.
  • Cool Company Ltd. CLCO shares fell 5.3% to $12.72 after reporting results for the third quarter.

Β 

Β 

Now Read This: Top 5 Risk Off Stocks Which Could Rescue Your Portfolio This Month


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.